Yasutomi Asano

Discovery of an Orally Bioavailable, Brain-Penetrating, in Vivo Active Phosphodiesterase 2A Inhibitor Lead Series for the Treatment of Cognitive Disorders.

H. Oki, S. Mikami, O. Ujikawa, 2017, Journal of medicinal chemistry.

Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (2).

Toshimasa Tanaka, T. Kawamoto, M. Yamaguchi, 2008, Bioorganic & medicinal chemistry.

Pharmacological characterization of synthetic serine palmitoyltransferase inhibitors by biochemical and cellular analyses.

K. Ogawa, T. Kawamoto, R. Adachi, 2016, Biochemical and biophysical research communications.

Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1).

Toshimasa Tanaka, T. Kawamoto, M. Yamaguchi, 2008, Bioorganic & medicinal chemistry.

Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode.

M. Klein, R. Tjhen, Biching Sang, 2019, ACS medicinal chemistry letters.

Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (2).

Toshimasa Tanaka, T. Kawamoto, M. Yamaguchi, 2008, Bioorganic & medicinal chemistry.

The first asymmetric synthesis of a dopamine D1 agonist, dihydrexidine, employing asymmetric conjugate addition technology

K. Tomioka, M. Yamashita, Ken‐ichi Yamada, 2001 .